Association of Anti–Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti–Topoisomerase I–Positive Systemic Sclerosis

OBJECTIVE: Anti–topoisomerase I (anti–topo I) autoantibodies in systemic sclerosis (SSc) are associated with diffuse skin involvement and interstitial lung fibrosis. Thus far, however, the relationship between anti–topo I antibody response and disease course has not yet been fully evaluated. This st...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonstra, Maaike, Bakker, Jaap A., Grummels, Annette, Ninaber, Maarten K., Ajmone Marsan, Nina, Wortel, Corrie M., Huizinga, Tom W. J., Jordan, Suzana, Hoffman‐Vold, Anna‐Maria, Distler, Oliver, Toes, René E. M., Scherer, Hans Ulrich, de Vries‐Bouwstra, Jeska K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Systemic Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702063/
https://www.ncbi.nlm.nih.gov/pubmed/32840062
http://dx.doi.org/10.1002/art.41403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702063/
https://www.ncbi.nlm.nih.gov/pubmed/32840062
http://dx.doi.org/10.1002/art.41403

Ejemplares similares